tiprankstipranks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
ESLA
Estrella Immunopharma
RESEARCH TOOLSreports
Want to see ESLA full AI Analyst Report?

Estrella Immunopharma (ESLA) Income Statement

39 Followers

Estrella Immunopharma Income Statement

Last quarter (Q4 2025), Estrella Immunopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Estrella Immunopharma's net income was $-613.17K. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Jun 24Dec 22Jun 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.06M$ 8.85M$ 7.31M$ 1.57M$ 1.69M
Depreciation and Amortization
$ 0.00$ -39.59K$ 0.00$ 228.49K$ 236.56K
EBITDA
$ -13.06M$ -8.85M$ -7.31M$ -686.97K$ -11.16K
Operating Income
$ -13.06M$ -8.85M$ -7.31M$ -1.57M$ -1.69M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 654.07K$ 1.44M
Pretax Income
$ -13.06M$ -8.85M$ -7.31M$ -915.46K$ -1.69M
Net Income
$ -13.06M$ -8.85M$ -7.31M$ -996.10K$ -1.69M
Per Share Metrics
Basic EPS
$ -0.35$ -0.25$ -0.21$ -0.17$ -0.29
Diluted EPS
$ -0.35$ -0.25$ -0.21$ -0.17$ -0.29
Weighted Average Shares Outstanding
 36.82M 36.68M 35.20M 5.76M 5.85M
Weighted Average Shares Outstanding (Diluted)
 36.82M 36.68M 35.20M 5.76M 5.85M
Currency in USD

Estrella Immunopharma Earnings and Revenue History